• 1. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 2. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 3. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431

• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

3-Methyl-1,2-benzisoxazol-6-ol (CAS No. 66033-92-9): Properties, Applications, and Market Insights

3-Methyl-1,2-benzisoxazol-6-ol (CAS No. 66033-92-9) is a heterocyclic organic compound that has garnered significant attention in pharmaceutical and agrochemical research. This compound, characterized by its benzisoxazole core structure, serves as a key intermediate in the synthesis of various bioactive molecules. Its unique chemical properties make it a valuable building block in medicinal chemistry, particularly in the development of central nervous system (CNS) targeting drugs and antimicrobial agents.

The molecular formula of 3-Methyl-1,2-benzisoxazol-6-ol is C₈H₇NO₂, with a molecular weight of 149.15 g/mol. The presence of both the methyl group and the hydroxyl group on the benzisoxazole ring contributes to its distinct reactivity profile. Researchers have explored its potential in creating derivatives with enhanced pharmacological activity, particularly in modulating neurotransmitter systems. Recent studies highlight its role in developing novel GABA receptor modulators, a hot topic in neuroscience research.

In the pharmaceutical industry, 3-Methyl-1,2-benzisoxazol-6-ol derivatives have shown promise in addressing current healthcare challenges. With the growing global focus on mental health disorders and neurodegenerative diseases, this compound has emerged as a potential scaffold for designing next-generation therapeutics. Its structural features allow for precise modifications to improve blood-brain barrier permeability – a critical factor in CNS drug development that's frequently searched in academic databases and AI-powered research tools.

The agrochemical sector has also shown interest in 3-Methyl-1,2-benzisoxazol-6-ol based compounds. As sustainable agriculture gains momentum worldwide, researchers are investigating its derivatives as potential eco-friendly pesticides with reduced environmental persistence. This aligns perfectly with current trends in green chemistry and the search for alternatives to traditional crop protection agents – topics that consistently rank high in scientific search queries.

From a synthetic chemistry perspective, 66033-92-9 offers several advantages. Its relatively simple structure allows for cost-effective production while providing multiple sites for chemical modification. Recent publications demonstrate innovative routes to functionalize the benzisoxazole scaffold, including metal-catalyzed cross-coupling reactions and photochemical transformations – techniques that dominate current organic chemistry literature searches.

The global market for benzisoxazole derivatives is experiencing steady growth, driven by increasing R&D investments in life sciences. Pharmaceutical companies are particularly interested in 3-Methyl-1,2-benzisoxazol-6-ol as a precursor for potential antipsychotic and anxiolytic medications. Market analysts note rising demand in Asia-Pacific regions, where mental health awareness is growing rapidly – a trend reflected in regional search engine patterns for neuropharmacology compounds.

Quality control of CAS 66033-92-9 follows stringent pharmaceutical standards, with HPLC purity typically exceeding 98%. Analytical methods for this compound are well-documented, addressing another common search query among quality assurance professionals. The compound's stability under standard storage conditions makes it attractive for industrial applications, though proper handling protocols should always be followed.

Recent patent filings reveal innovative applications of 3-Methyl-1,2-benzisoxazol-6-ol in material science, particularly in developing organic electronic materials. This unexpected expansion of its utility has sparked new research directions, demonstrating how fundamental chemical building blocks can find applications in cutting-edge technologies – a crossover topic that generates significant interest across multiple scientific disciplines.

For researchers working with 66033-92-9, understanding its spectroscopic characteristics is crucial. The compound displays distinctive peaks in both NMR and IR spectra, which serve as important quality indicators. These analytical aspects represent some of the most searched technical details about this compound in academic and industrial settings.

Environmental fate studies of 3-Methyl-1,2-benzisoxazol-6-ol indicate moderate biodegradability, an important consideration given current regulatory trends toward sustainable chemistry. This aspect frequently appears in environmental impact assessments and regulatory submissions, making it another relevant point for professionals searching information about this compound.

Looking ahead, the scientific community anticipates expanded applications for 3-Methyl-1,2-benzisoxazol-6-ol in drug discovery programs. Its versatility as a molecular scaffold positions it well to address emerging therapeutic needs, particularly in the rapidly evolving fields of precision medicine and personalized therapeutics – two of the most searched healthcare innovation topics in recent years.

In conclusion, CAS 66033-92-9 represents more than just a chemical compound – it embodies the intersection of traditional medicinal chemistry with modern therapeutic challenges. Its continued relevance in both established and emerging applications ensures that 3-Methyl-1,2-benzisoxazol-6-ol will remain a subject of active research and commercial interest for years to come.

• 73344-39-5(1,2-BENZISOXAZOLE, 6-METHOXY-3-METHYL-)
• 214760-33-5(1,2-Benzisoxazol-7-ol, 3-methyl- (9CI))
• 37924-91-7(1,2-Benzisoxazole-3-methanol,5-hydroxy-(9CI))
• 145508-90-3(1,2-Benzisoxazole,5-methoxy-3-methyl-)
• 4825-75-6(3-Methyl-1,2-benzisoxazole)
• 29505-13-3(1,2-Benzisoxazole,3,6-dimethyl-)
• 214760-36-8(1,2-Benzisoxazol-5-ol, 3-methyl- (9CI))
• 148321-62-4(1,2-Benzisoxazol-6-ol,3,7-dimethyl-)
• 53155-26-3(1,2-benzisoxazole, 3,5-dimethyl-)
• 51110-58-8(3-Methyl-benzodisoxazol-4-ol)